Preliminary observations suggesting that treatment with modafinil improves fatigue in patients with orthostatic intolerance

American Journal of Therapeutics

Volumn 18, Issue 6, 2011, Pages 449-452

  Kanjwal, Khalil ^a   Saeed, Bilal ^a   Karabin, Beverly ^a   Kanjwal, Yousuf ^a   Grubb, Blair P ^a  

^a UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

Author keywords

fatigue; modafinil; orthostatic intolerance; postural orthostatic tachycardia

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; ERYTHROPOIETIN; FLUDROCORTISONE; METHYLPHENIDATE; MIDODRINE; MODAFINIL; PYRIDOSTIGMINE; SEROTONIN UPTAKE INHIBITOR; SODIUM;

ADULT; ARTICLE; COMORBIDITY; DAILY LIFE ACTIVITY; DIET THERAPY; DRUG TREATMENT FAILURE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC INTOLERANCE; PALLIATIVE THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; ORTHOSTATIC INTOLERANCE; RETROSPECTIVE STUDIES; TILT-TABLE TEST; TREATMENT OUTCOME;

EID: 81755161252     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181da0763     Document Type: Article

References (20)

1. Grubb BP.Dysautonomic (orthostatic) syncope. In: Grubb BP, Olshansky B, eds. Syncope: Mechanisms and Management. Malden, MA: Blackwell Publishing; 2005:72-91.
2. Grubb BP. Neurocardiogenic Syncope. In: Grubb BP, Olshansky B (eds.). Syncope: Mechanisms and Management. Malden, MA: Blackwell Publishing; 2005:47-71.
3. Grubb BP. Neurocardiogenic syncope and related disorders of orthostatic intolerance. Circulation. 2005;111: 2997-3006. (Pubitemid 40814194)
4. Grubb BP. Postural orthostatic tachycardia. Circulation. 2008;117;2814-2817.
5. Grubb BP, Kanjwal Y, Kosinski DJ. The postural tachycardia syndrome: a concise guide to diagnosis and management. J Cardiovasc Electrophysiol. 2006;17:108-112.
6. Littleton ET, Hobart JC, Palace J. Modafinil for multiple sclerosis fatigue:does it work? Clin Neurol Neurosurg. 2010;112:29-31. Epub October 17, 2009.
7. Brioschi A, Gramigna S,Werth E, et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol. 2009;62:243-249. Epub August 7, 2009.
8. Lange R, Volkmer M, Heesen C, et al. Modafinil effects in multiple sclerosis patients with fatigue. J Neurol. 2009;256: 645-650. Epub April, 2009.
9. Dworzańska E, Mitosek-Szewczyk K, Stelmasiak Z. [Fatigue in multiple sclerosis]. Neurol Neurochir Pol. 2009;43: 71-76. Review. Polish.
10. Lou JS, Dimitrova DM, Park BS, et al. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study. Clin Neuropharmacol. 2009; 32:305-310.
11. Lou JS. Physical and mental fatigue in Parkinson's disease: epidemiology, pathophysiology and treatment. Drugs Aging. 2009;26:195-208. doi: 10.2165/00002512-200926030-00002. Review.
12. Freudenreich O, Henderson DC, Macklin EA, et al. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. J Clin Psychiatry. 2009;70:1674-1680.
13. Cooper MR, Bird HM, Steinberg M. Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Ann Pharmacother. 2009;43:721-725. Epub March 24, 2009. Review.
14. Spathis A, Dhillan R, Booden D, et al. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med. 2009;23:325-331. Epub March 6, 2009.
15. Rabkin JG, Gordon PH, McElhiney M, et al. Modafinil treatment of fatigue in patients with ALS: a placebocontrolled study. Muscle Nerve. 2009;39:297-303.
16. Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs. 2008;68:1803-1839.
17. Minzenberg MJ, Carter CS. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 2008;33:1477-1502 (Pubitemid 351684703)
18. Ferraro L, Antonelli T, O'Connor WT, et al. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett. 1998;253:135-138. (Pubitemid 28430641)
19. Ferraro L, Tanganelli S, O'Connor WT, et al. The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett. 1996;220.
20. Ferraro L, Fuxe K, Tanganelli S, et al. Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression. J Neurosci Res. 2002;68: 107-112. (Pubitemid 34275003)